Kidneys And Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report Provides Detail On The Top 20 Companies With Products In The Early And Late Stage Of Development.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c68987) has announced the addition of Kidneys kidneys: see urinary system. and Genito-Urinary System - Benign Prostatic Hyperplasia benign prostatic hyperplasia n. Abbr. BPH A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine. Drug Pipeline Report to their offering. "Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of benign prostatic hyperplasia drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular tab·u·lar adj. 1. Having a plane surface; flat. 2. Organized as a table or list. 3. Calculated by means of a table. tabular resembling a table. format on a company's full product pipeline and products by phase of development with regard to the therapy area. Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products. Key benefits - Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas. - Keep track of your competitors COMPETITORS, French law. Persons who compete or aspire to the same office, rank or employment. As an English word in common use, it has a much wider application. Ferriere, Dict. de Dr. h.t. and partners by better understanding their product pipeline. - Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas. - Maintain a critical competitive advantage. Content Outline: RECENT HIGHLIGHTS AND CHANGES --Recent Highlights and Changes UPCOMING PATENT EXPIRES BY THERAPY AREA Benign Prostatic Hyperplasia Pipeline Overview --% of Projects (By Phase of Development) --No. of Projects by Phase of Development --Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects --Company Overview - Pipeline Projects --Legend --Top 20 companies in late stage Benign Prostatic Hyperplasia Projects --Top 20 companies in early stage Benign Prostatic Hyperplasia Projects Full Pipeline View --Pre Clinical Pipeline View --Phase I Pipeline View --Phase II Pipeline View For more information visit http://www.researchandmarkets.com/reports/c68987. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion